However, MM cells surviving Bz treatment downregulated eIF2α phosphorylation, upregulated the survival chaperone BiP/GRP78 and entered a prolonged G0-G1 cell cycle arrest. The gene discussed is EIF2A; the disease is Miyoshi myopathy.